Trump Nominates Heidi Overton to Lead FDA

WASHINGTON — President Donald Trump has nominated physician and White House policy aide Heidi Overton to become the next commissioner of the Food and Drug Administration, putting a new leadership choice before the Senate.

Overton's nomination comes during a difficult period for the FDA, which has experienced significant staff departures and continuing debate over the direction of federal health regulation.

The nomination will require Senate confirmation. Pharmaceutical companies and agency employees are watching closely to see whether the new leadership will prioritize faster drug approvals, regulatory changes and the administration's broader healthcare agenda.

The FDA is also dealing with several major public-health and medical-device issues, including food-safety investigations and the development of regulatory approaches for generative AI-enabled medical devices.

Overton's potential appointment could therefore have a significant impact on U.S. drug approvals, medical-device regulation and the future direction of the FDA.